Giant cell arteritis (GCA) is the most frequent primary systemic vasculitis in adults, involving medium-to-large-sized ...

Delays in starting tocilizumab therapy for giant cell arteritis are caused partly by delays in insurance approval, and costs ...

The exact link between PMR and GCA is still unknown.Diagnosis of Giant Cell ArteritisDiagnosing Giant Cell Arteritis involves clinical evaluation and imaging or lab tests:- Physical Examination:a.

SHREVEPORT, La. - Giant cell arteritis, also known as temporal arteritis, is a less common condition where people get inflammation of the arteries that go to the head and neck.

Patients with giant cell arteritis who use anticoagulants demonstrate lower risks for vision loss, stroke and other cranial ischemic complications, according to data published in Annals of the ...

Giant Cell Arteritis (GCA): A form of vasculitis affecting large and medium-sized arteries, predominantly in individuals over 50, potentially leading to serious vascular complications such as ...

on Thursday released topline results from the Phase 3 GCAptAIN study evaluating Cosentyx (secukinumab) for newly diagnosed or relapsing giant cell arteritis (GCA). Giant cell arteritis is an ...

The positive association between incident giant cell arteritis and concentrations of PM10 was seen only when patients were exposed to high concentrations of PM 10 (26.9 ± 13.8 μg/m 3) but not ...

The Food and Drug Administration (FDA) has approved Rinvoq ® (upadacitinib), a Janus kinase (JAK) inhibitor, for the treatment of adults with giant cell arteritis (GCA). The approval was based on ...

KIAWAH ISLAND, S.C. — Temporal artery ultrasound and EULAR score are reliable means for diagnosing giant cell arteritis, Mercy Bechtold, MD, said during her presentation at Kiawah Eye.